AmerisourceBergen Corporation

    Jurisdiction
    United States
    LEI
    AI8GXW8LG5WK7E9UD086
    ISIN
    US03073E1055 (ABC)
    Sectors
    1. Healthcare
    2. Medical - Distribution

    Scores

    InsiderPie Expert Score
    56 / 100
    Better than peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €299.85 10.5% undervalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Cencora, Inc. sources and distributes pharmaceutical products. Read full profile

    Fundamentals

    Net revenue
    €275.88B
    Gross margin
    3.5%
    EBIT
    €2.40B
    EBIT margin
    0.9%
    Net income
    €1.68B
    Net margin
    0.6%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €291.85B +5.8% €2.87B +70.7%
    €313.00B +7.2% €3.12B +8.8%
    €341.11B +9.0% €3.49B +11.8%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.55
    Ex date
    Payment date
    Dividend payout ratio
    32.8%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    COLLIS STEVEN H Executive Chairman -15K $289.98 -$4.23M
    Mauch Robert P. President & CEO -5K $293.53 -$1.46M
    COLLIS STEVEN H Executive Chairman -15K $292.67 -$4.27M
    Mauch Robert P. President & CEO -5K $294.11 -$1.46M

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Ray Dalio 14K $3.80M -184K Sell

    Earnings Calls

    Latest earnings call: August 6, 2025 (Q3 2025)

    Add to watchlist

    Notifications